Arch Biopartners (TSXV:ARCH) Interest Expense : C$-0.38 Mil (TTM As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Arch Biopartners Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Arch Biopartners's interest expense for the three months ended in Dec. 2023 was C$ -0.09 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.38 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Arch Biopartners's Operating Income for the three months ended in Dec. 2023 was C$ -0.70 Mil. Arch Biopartners's Interest Expense for the three months ended in Dec. 2023 was C$ -0.09 Mil. Arch Biopartners did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Arch Biopartners Interest Expense Historical Data

The historical data trend for Arch Biopartners's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Biopartners Interest Expense Chart

Arch Biopartners Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Interest Expense

Get a 7-Day Free Trial

-0.11

-0.18

-0.27

-0.31

-0.36

Arch Biopartners Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.07	-0.07	-0.10	-0.12	-0.09

Arch Biopartners Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.38 Mil.

Arch Biopartners (TSXV:ARCH) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Arch Biopartners's Interest Expense for the three months ended in Dec. 2023 was C$-0.09 Mil. Its Operating Income for the three months ended in Dec. 2023 was C$-0.70 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was C$0.50 Mil.

Arch Biopartners's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Arch Biopartners did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Arch Biopartners (TSXV:ARCH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (TSXV:ARCH) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

545 King Street West, Toronto, ON, CAN, M5V 1M1

Website

https://www.archbiopartners.com

Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. It's under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.